Carlos Campoy

Insider Reports History

Location
Bothell, WA
Signature
/s/ Daniel Dex, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Carlos Campoy:

Company Role Class Num Shares Value Price $ Report Date Ownership
CytomX Therapeutics, Inc. Chief Financial Officer Common Stock 38,224 $52,776 $1.38 16 Mar 2023 Direct
Zymeworks Inc. Director Stock Option (Right to Buy) 11,500 12 Jan 2026 Direct
Zymeworks Inc. Director Restricted Stock Unit 7,700 12 Jan 2026 Direct

Insider Reports Filed by Carlos Campoy

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ZYME Zymeworks Inc. 12 Jan 2026 2 $0 4 Director 12 Jan 2026, 20:50
ZYME Zymeworks Inc. 10 Dec 2024 1 $0 4 Director 12 Dec 2024, 18:15
ZYME Zymeworks Inc. 07 Dec 2023 1 $0 4 Director 08 Dec 2023, 17:48
ZYME Zymeworks Inc. 30 Jun 2023 1 $0 4 Director 30 Jun 2023, 20:05
ZYME Zymeworks Inc. 30 Jun 2023 0 $0 3 Director 30 Jun 2023, 20:03
CTMX CytomX Therapeutics, Inc. 16 Mar 2023 1 -$3,459 4 Chief Financial Officer 20 Mar 2023, 18:43
CTMX CytomX Therapeutics, Inc. 19 Jul 2022 2 -$5,617 4 Chief Financial Officer 21 Jul 2022, 16:08
CTMX CytomX Therapeutics, Inc. 02 Feb 2022 2 $0 4 Chief Financial Officer 04 Feb 2022, 15:50
CTMX CytomX Therapeutics, Inc. 24 Oct 2021 2 $0 4 Chief Financial Officer 26 Oct 2021, 16:25
CTMX CytomX Therapeutics, Inc. 31 May 2021 1 +$20,206 4 Chief Financial Officer 08 Jun 2021, 13:08